Matches in Wikidata for { <http://www.wikidata.org/entity/Q57294470> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- Q57294470 description "article scientifique publié en 2018" @default.
- Q57294470 description "article" @default.
- Q57294470 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57294470 description "wetenschappelijk artikel" @default.
- Q57294470 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q57294470 name "A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults" @default.
- Q57294470 name "A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults" @default.
- Q57294470 type Item @default.
- Q57294470 label "A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults" @default.
- Q57294470 label "A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults" @default.
- Q57294470 prefLabel "A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults" @default.
- Q57294470 prefLabel "A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults" @default.
- Q57294470 P1433 Q57294470-BA425B13-FF4A-4A1A-BED6-EC828D38A228 @default.
- Q57294470 P1476 Q57294470-B5AE323F-203E-4EFE-A5D5-ECA6EA5B6069 @default.
- Q57294470 P2093 Q57294470-4C742760-F187-4B4D-B1B9-B5E08D38E6A8 @default.
- Q57294470 P2093 Q57294470-8450296F-8DCA-4E41-8443-2B43A2A2B0B5 @default.
- Q57294470 P2093 Q57294470-C7BE4DC9-EA3B-45D1-869B-74D1E910C0A8 @default.
- Q57294470 P2093 Q57294470-FCE5F322-B024-492D-88CD-A67D26476103 @default.
- Q57294470 P2860 Q57294470-1122750F-A4A7-4E9C-9FF9-90BC58917278 @default.
- Q57294470 P2860 Q57294470-21A75595-ED9D-4C51-AC9E-E4B7AE37CCB3 @default.
- Q57294470 P2860 Q57294470-40F0030C-830A-4247-9A7C-9E97242C78BD @default.
- Q57294470 P2860 Q57294470-44548A88-DF9D-4BEC-B958-82336E703E7A @default.
- Q57294470 P2860 Q57294470-605A0591-8BEA-407F-A508-570C1994E4CE @default.
- Q57294470 P2860 Q57294470-62A7A314-4419-4037-B86C-08A14A7FE1F3 @default.
- Q57294470 P2860 Q57294470-7F61F99A-AAF3-48EA-A960-1D61040EACA8 @default.
- Q57294470 P2860 Q57294470-E61E2E48-E606-461C-9F6C-185D3DB91843 @default.
- Q57294470 P304 Q57294470-3408C322-20BC-40B0-B7B9-6CFD2E798F11 @default.
- Q57294470 P31 Q57294470-E8E7E4E4-EE7E-4DC3-9453-F6349AA86BD5 @default.
- Q57294470 P356 Q57294470-1B6F6889-2E59-4FC6-8B78-4701463ED508 @default.
- Q57294470 P407 Q57294470-EB91450D-6976-440E-8371-71B9F408D448 @default.
- Q57294470 P433 Q57294470-D172A82B-32E8-42E3-A01B-3492EA391BDB @default.
- Q57294470 P478 Q57294470-732F2E80-9F3B-4294-AA3D-3D4939F68CE6 @default.
- Q57294470 P50 Q57294470-C6127668-9050-4541-969A-B2A2336153E4 @default.
- Q57294470 P50 Q57294470-F721F071-3EAB-4D18-BB8B-C3C4CA49B0FD @default.
- Q57294470 P577 Q57294470-74801AF6-0A07-4985-8834-54B1DFF09729 @default.
- Q57294470 P698 Q57294470-FC15022C-4A47-489E-A1C2-4724F62DC2C2 @default.
- Q57294470 P356 S15010-018-1233-2 @default.
- Q57294470 P698 30298473 @default.
- Q57294470 P1433 Q15710156 @default.
- Q57294470 P1476 "A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults" @default.
- Q57294470 P2093 "Carlos Fritzsche" @default.
- Q57294470 P2093 "Daniel Kirby" @default.
- Q57294470 P2093 "Emil C Reisinger" @default.
- Q57294470 P2093 "Esther Heijnen" @default.
- Q57294470 P2860 Q30355688 @default.
- Q57294470 P2860 Q30356208 @default.
- Q57294470 P2860 Q30397594 @default.
- Q57294470 P2860 Q34970364 @default.
- Q57294470 P2860 Q34984192 @default.
- Q57294470 P2860 Q36111407 @default.
- Q57294470 P2860 Q36333306 @default.
- Q57294470 P2860 Q51152487 @default.
- Q57294470 P304 "105-109" @default.
- Q57294470 P31 Q13442814 @default.
- Q57294470 P356 "10.1007/S15010-018-1233-2" @default.
- Q57294470 P407 Q1860 @default.
- Q57294470 P433 "1" @default.
- Q57294470 P478 "47" @default.
- Q57294470 P50 Q55729628 @default.
- Q57294470 P50 Q67598196 @default.
- Q57294470 P577 "2018-10-08T00:00:00Z" @default.
- Q57294470 P698 "30298473" @default.